BDBM50110070 3-Chloro-4-hydroxy-benzoic acid [1-[4-(tetrahydro-pyran-2-ylmethoxy)-naphthalen-1-yl]-meth-(E)-ylidene]-hydrazide::CHEMBL351724
SMILES: Oc1ccc(cc1Cl)C(=O)N\N=C\c1ccc(OCC2CCCCO2)c2ccccc12
InChI Key: InChIKey=PKXKSFUIKNZGAP-VULFUBBASA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glucagon receptor (Homo sapiens (Human)) | BDBM50110070![]() (3-Chloro-4-hydroxy-benzoic acid [1-[4-(tetrahydro-...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem Patents | PubMed | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Global Research and Development Curated by ChEMBL | Assay Description In vitro inhibitory activity against human glucagon receptor using [127I]-labeled glucagon | Bioorg Med Chem Lett 12: 663-6 (2002) BindingDB Entry DOI: 10.7270/Q2J67G77 | |||||||||||
More data for this Ligand-Target Pair |